Skip to main content

Reblozyl 25 mg lyophilized powder for injection Images

Generic Name: luspatercept

This medication has been identified as Reblozyl 25 mg lyophilized powder for injection. It is supplied by Celgene Corporation.

Reblozyl is used in the treatment of Myelodysplastic Syndrome; Anemia; Beta Thalassemia and belongs to the drug class miscellaneous erythropoiesis agents. Reblozyl 25 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Reblozyl 25 mg lyophilized powder for injection medicine

Reblozyl

Generic Name
luspatercept
Strength
25 mg lyophilized powder for injection
Availability
Prescription only
Drug Class
Miscellaneous erythropoiesis agents
CSA Schedule
Not a controlled drug
Labeler / Supplier
Celgene Corporation
National Drug Code (NDC)
59572-0711

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.